Search

everythinglearnresearchcommunity

for

Search:↓

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Using anabolic steroids 'Sus' and 'Deca' for bodybuilding caused severe acne in a man.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

New compounds were made that are promising for prostate cancer therapy.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

Mutations in the androgen receptor gene cause androgen insensitivity, leading to female traits in genetically male individuals.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.